|

Breath-holding Spells and Its Management Study

RECRUITINGN/ASponsored by Region Skane
Actively Recruiting
PhaseN/A
SponsorRegion Skane
Started2024-12-02
Est. completion2030-12
Eligibility
Age0 Months – 60 Months
Healthy vol.Accepted

Summary

The goal of this prospective population-based study is to evaluate the new disease description and management guidelines for breath-holding spells in children (Hellström Schmidt et al, Acta Paediatrica 2024) below the age of 5 years in southern Sweden. The main questions it aims to answer are: * Does the disease description and management guidelines lead to the expected reduction in diagnostic interventions and are the clinical managements guidelines safe to use? * If iron supplementation is given, does it reduce the frequency and severity of the spells? * What information and support does parents to children with breath-holding spells need? Participants will undergo evaluation by a medical doctor and if typical breath-holding spells are diagnosed, be managed according to the new guidelines. If iron deficiency is found, iron supplementation is recommended. Digital surveys will be distributed and parents of patients with frequent spells will be eligible for participation in an interview sub-study.

Eligibility

Age: 0 Months – 60 MonthsHealthy volunteers accepted
Inclusion Criteria:

* Below 5 years of age
* resident in Region Skåne (Sweden)
* suspected breath-holding spell

Exclusion Criteria:

* previous investigation for breath-holding spell (previous spells are not a reason for exclusion)

Conditions2

Breath-holding SpellHeart Disease

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.